Search
  • healthinnovation

Innovation News and Articles

(La version française suit.)

Announcements:


Winners of the 2021 Digital Health Canada Awards


Takeda Canada Launches Digital Health Innovation Challenge to Canada's Inspiring Tech Community

Takeda Canada Inc. has launched the Takeda Canada Innovation Challenge which aims to discover new and breakthrough digital technologies and artificial intelligence solutions supporting enhanced patient care. In particular, in the field of early diagnosis or integrated and personalized care. The winner(s) of the challenge will be provided with the support to build a proof-of-concept project with a Takeda team.

Purpose Investments Announces Launch of Purpose Healthcare Innovation Yield ETF, Canada's First Fund to Focus on Innovation in Biotech and Healthcare

Purpose Investment Inc. has launched Purpose Healthcare Innovation Yield ETF (the “Fund”), the first of its kind in Canada to provide Canadians with the opportunity to get actively managed exposure to innovation leaders in biotech and healthcare. The Fund will be investing in the areas of gene-editing, digital healthcare, medical testing, dental, health maintenance, hospitals, pharmacies, and animal health.



Ontario Strengthening Province’s Research and Innovation Sector

The Ontario government is investing more than $240 million over three years in leading research institutes across the province to strengthen Ontario innovation. This investment will ensure access to state-of-the-art technology, talent and equipment for the Ontario Institute for Cancer Research, Ontario Genomics, Clinical Trials Ontario, The Fields Institute and Compute Ontario.


New CIHR‑funded collaboration between Dalhousie and the University of Calgary to address health inequities of incarcerated Indigenous women


ZetaMet Receives Health Canada Authorization for Phase 2a Study in Treating Metastatic Bone Lesions


Notch Therapeutics' Peter Zandstra Appointed to the Order of Canada

The Chief Scientific Officer and scientific co-founder of Notch Therapeutics Inc., Peter Zandstra, has been appointed to the 2021 Order of Canada, one of the highest honours of the country. In 2018, he co-founded Notch, a biotechnology company developing stem cell therapies for cancer. This appointment recognizes his leadership in stem cell bioengineering and inspiring health innovations.


Sinai Health, U of T's Lawrence S. Bloomberg Faculty of Nursing collaborate on Centre for Nursing Excellence


Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada


SQI Diagnostics Inc Congratulates its Partner UHN for Winning $24 Million Award from Government of Canada


Ottawa’s new science grant recipients to tackle complex challenges, including Indigenous-led solutions to stem biodiversity loss


UHN and U of T receive $24-million federal grant for transplant research


Competition Bureau and Health Canada strengthen collaboration on key issues in pharmaceutical industry


Grifols acquires its first plasma donation center in Canada


Bausch (BHC) Eye Care Business Files for IPO in the US & Canada


MedX Health Corp. Announces Addition of Three New Screening Services Locations Across Ontario


JAMP and Alvotech Announce Canadian Approval of SIMLANDI, a High-Concentration Biosimilar to Humira, Providing Access to Previously Unavailable Versions in Canada


League enters 2022 as Canada’s newest unicorn with TDM Growth Partners-led round


Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients


Levitee Labs Announces Non-Brokered Private Placement of up to $3,000,000


Doseology Appoints Maryam Marissen as CEO to Prepare for Next Growth Stage


Aequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma Medication


LifeSpeak Releases the Next Generation of Intuitive Mental Health and Wellness Support with Latest Platform Updates




Articles


Flooding the Market: How Canada Became a Period Product Hotspot


Pandemic has driven homegrown health-care innovation. How do we maintain the momentum?

The pandemic has emphasized the importance of collaboration between public and private sectors in advancing health-care innovation. This is illustrated through Vancouver Coastal Health’s extensive partnerships ensuring enhanced public safety during the pandemic.


Experts explore strategies for strengthening Canada’s bioinnovation ecosystem at Medicine by Design event

The symposium “A Systems Approach to Regenerative Medicine” hosted by the University of Toronto’s Medicine by Design program explored strengthening the bioinnovation ecosystem and the impact of COVID-19 on the bioinnovation pipeline.


GGH life sciences sector has potential, but needs space, funding


Global Digital Health Market and Trends Report 2021: B2B Market Shifts Towards Digital Sales Amid COVID-19


AI Innovations Accelerated By Government And Business Leadership Fight Against COVID-19.

With the persistence of COVID-19, global governments are taking actions to advance COVID-19 research and stimulate innovation. For example, Canadian government AI research grants are funding projects using AI methods to fight COVID-19 such as using medical imaging and AI to predict severity of COVID-19 infection, understanding which drugs may be effective in treatment and understanding how the virus is mutating.


 

Nouvelles

Takeda Canada Launches Digital Health Innovation Challenge to Canada's Inspiring Tech Community

Takeda Canada Inc. a lancé le Défi d'innovation Takeda Canada qui vise à découvrir de nouvelles technologies numériques révolutionnaires et des solutions d'intelligence artificielle soutenant l'amélioration des soins aux patients. Notamment dans le domaine du diagnostic précoce ou de la prise en charge intégrée et personnalisée des soins. Le(s) gagnant(s) du défi bénéficieront d'un soutien pour construire un projet de preuve de concept avec une équipe Takeda.


Purpose Investments Announces Launch of Purpose Healthcare Innovation Yield ETF, Canada's First Fund to Focus on Innovation in Biotech and Healthcare

Purpose Investment Inc. a lancé le FNB Purpose Healthcare Innovation Yield (le « Fonds »), le premier du genre au Canada à offrir aux Canadiens la possibilité d'obtenir une exposition activement gérée aux leaders de l'innovation dans les biotechnologies et les soins de santé. Le Fonds investira dans les domaines de l'édition de gènes, des soins de santé numériques, des tests médicaux, des soins dentaires, de l'entretien de la santé, des hôpitaux, des pharmacies et de la santé animale.



Ontario Strengthening Province’s Research and Innovation Sector

Le gouvernement de l'Ontario investit plus de 240 millions de dollars sur trois ans dans les principaux instituts de recherche de la province afin de renforcer l'innovation en Ontario. Cet investissement garantira l'accès à une technologie, des talents et de l'équipement de pointe pour l'Institut ontarien de recherche sur le cancer, Ontario Genomics, Clinical Trials Ontario, The Fields Institute et Compute Ontario.



Notch Therapeutics' Peter Zandstra Appointed to the Order of Canada

Le directeur scientifique et cofondateur scientifique de Notch Therapeutics Inc., Peter Zandstra, a été nommé à l'Ordre du Canada 2021, l'une des plus hautes distinctions du pays. En 2018, il a cofondé Notch, une société de biotechnologie développant des thérapies à base de cellules souches contre le cancer. Cette nomination reconnaît son leadership dans la bio-ingénierie des cellules souches et ses innovations inspirantes en santé.


Pandemic has driven homegrown health-care innovation. How do we maintain the momentum?

La pandémie a souligné l'importance de la collaboration entre les secteurs public et privé pour faire progresser l'innovation en matière de soins de santé. Ceci est illustré par les vastes partenariats de Vancouver Coastal Health assurant une sécurité publique accrue pendant la pandémie

.


Experts explore strategies for strengthening Canada’s bioinnovation ecosystem at Medicine by Design event

Le symposium « A Systems Approach to Regenerative Medicine » organisé par le programme Medicine by Design de l'Université de Toronto a exploré le renforcement de l'écosystème de la bioinnovation et l'impact de la COVID-19 sur le pipeline de la bioinnovation.



AI Innovations Accelerated By Government And Business Leadership Fight Against COVID-19.

Avec la persistance de la COVID-19, les gouvernements mondiaux prennent des mesures pour faire avancer la recherche sur la COVID-19 et stimuler l'innovation. Par exemple, les subventions de recherche du gouvernement canadien sur l'IA financent des projets utilisant des méthodes d'IA pour lutter contre la COVID-19, comme l'utilisation de l'imagerie médicale et de l'IA pour prédire la gravité de l'infection par la COVID-19, comprendre quels médicaments peuvent être efficaces dans le traitement et comprendre comment le virus mute.



10 views1 comment

Recent Posts

See All

EVENTS

  • One Health Connect 2021
    Thu, Sept 23
    Virtual Event
    Join us and our panel of world-leading experts from each of the domains of One Health to highlight the importance of trans disciplinary approaches to address present and future challenges that threaten human, animal, and environmental health.
    Share
  • Health Startup Day 2021
    Wed, Mar 24
    Zoom
    Join our diverse invited speakers as they discuss the transition from academia to their current professions with an emphasis on digital health.
    Share
  • Catalysing Collaborations | Catalyser les collaborations
    Thu, Jul 16
    Zoom
    2020 is pushing boundaries and challenging norms. Let's collaborate and understand each other better. 2020 repousse les limites et défie les normes. Collaborons afin de mieux nous comprendre.
    Share
  • Health Startup Day 2020 | Journée de démarrage de la santé 2020
    Wed, Feb 26
    Thomson House, 3650 Mc Tavish St, Montreal, QC H3A 1X9, Canada
    We have invited speakers who are entrepreneurs and industry professionals with post-secondary level research experience. They will share how they transitioned beyond academia and into their current professions, as well as how they continue to work with researchers and universities.
    Share